---
figid: PMC6478123__mjz012f02
figlink: /pmc/articles/PMC6478123/figure/mjz012F2/
number: Figure 2
caption: Regulation of fatty acid oxidation, mevalonate pathway, and arachidonic acid
  metabolism by p53. SREBP transcription factors are regulated by p53 through multiple
  mechanisms, with an overall effect on inhibiting de novo fatty acid synthesis and
  the mevalonate pathway. Statins inhibit HMG-CoA synthase and are shown to inhibit
  growth of mutant p53 tumors, as well as restore normal mammary architecture in vitro.
  p53 promotes the fatty acid oxidation pathway in an AMPK-dependent manner as part
  of its metabolic remodeling activity in response to, for example, low glucose conditions.
  Metformin stimulates AMPK activity and β-oxidation of fatty acids, promoting survival
  in cells with wild-type p53, and impairs growth of p53-deficient cells. Niclosamide
  stimulates the production of arachidonic acids from phospholipids turnover. p53–ALOX5/12B
  axis protects cells from arachidonic acid (AA)-induced apoptosis, whereas cells
  lacking wild-type p53 are susceptible to AA-induced metabolic catastrophe.
pmcid: PMC6478123
papertitle: Drugging in the absence of p53.
reftext: Obed Akwasi Aning, et al. J Mol Cell Biol. 2019 Mar;11(3):255-264.
pmc_ranked_result_index: '5606'
pathway_score: 0.9578239
filename: mjz012f02.jpg
figtitle: Regulation of fatty acid oxidation, mevalonate pathway, and arachidonic
  acid metabolism by p53
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6478123__mjz012f02.html
  '@type': Dataset
  description: Regulation of fatty acid oxidation, mevalonate pathway, and arachidonic
    acid metabolism by p53. SREBP transcription factors are regulated by p53 through
    multiple mechanisms, with an overall effect on inhibiting de novo fatty acid synthesis
    and the mevalonate pathway. Statins inhibit HMG-CoA synthase and are shown to
    inhibit growth of mutant p53 tumors, as well as restore normal mammary architecture
    in vitro. p53 promotes the fatty acid oxidation pathway in an AMPK-dependent manner
    as part of its metabolic remodeling activity in response to, for example, low
    glucose conditions. Metformin stimulates AMPK activity and β-oxidation of fatty
    acids, promoting survival in cells with wild-type p53, and impairs growth of p53-deficient
    cells. Niclosamide stimulates the production of arachidonic acids from phospholipids
    turnover. p53–ALOX5/12B axis protects cells from arachidonic acid (AA)-induced
    apoptosis, whereas cells lacking wild-type p53 are susceptible to AA-induced metabolic
    catastrophe.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CD
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - ACACA
  - ACACB
  - ACLY
  - ALOX5
  - PRKAG1
  - PRKAG2
  - PRKAB2
  - CHPT1
  - FAS
  - GAMT
  - LPIN1
  - TP53
  - AKT1
  - AKT3
  - AKT2
  - MTOR
  - PANK1
  - PIK3R3
  - PIK3R6
  - PRKAB1
  - PIK3CG
  - PIK3CB
  - SREBF2
  - SREBF1
  - RPTOR
  - PRKAA1
  - PRKAA2
  - PRKAG3
  - arachidonic
  - 12B-H
  - niclosamide
  - Statins
  - Triglycerides
  - Mevalonate
  - fatty acids
  - Acetyl CoA
  - Fatty acids
  - creatine
  - TCA
  - Metformin
  - citrate
  - NADH
genes:
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: ACLY
  symbol: ACLY
  source: hgnc_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: ALOX5/12B-H
  symbol: ALOX5
  source: hgnc_symbol
  hgnc_symbol: ALOX5
  entrez: '240'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: CPT1
  symbol: CPT1
  source: hgnc_alias_symbol
  hgnc_symbol: CHPT1
  entrez: '56994'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: GAMT
  symbol: GAMT
  source: hgnc_symbol
  hgnc_symbol: GAMT
  entrez: '2593'
- word: LPIN1
  symbol: LPIN1
  source: hgnc_symbol
  hgnc_symbol: LPIN1
  entrez: '23175'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: +p53HPI3-K/Akt/MTORC1
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: +p53HPI3-K/Akt/MTORC1
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: +p53HPI3-K/Akt/MTORC1
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: +p53HPI3-K/Akt/MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PANK1
  symbol: PANK1
  source: hgnc_symbol
  hgnc_symbol: PANK1
  entrez: '53354'
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3-K/Akt/MTORC1
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: SREBP1/2
  symbol: SREBP2
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF2
  entrez: '6721'
- word: SREBP1/2
  symbol: SREBP1
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: +p53HPI3-K/Akt/MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
chemicals:
- word: arachidonic
  source: MESH
  identifier: D001095
- word: 12B-H
  source: MESH
  identifier: C057499
- word: niclosamide
  source: MESH
  identifier: D009534
- word: Statins
  source: MESH
  identifier: D019821
- word: Triglycerides
  source: MESH
  identifier: D014280
- word: Mevalonate
  source: MESH
  identifier: D008798
- word: fatty acids
  source: MESH
  identifier: D005227
- word: Acetyl CoA
  source: MESH
  identifier: D000105
- word: Fatty acids
  source: MESH
  identifier: D005227
- word: creatine
  source: MESH
  identifier: D003401
- word: TCA
  source: MESH
  identifier: C000589078
- word: Metformin
  source: MESH
  identifier: D008687
- word: citrate
  source: MESH
  identifier: C102006
- word: NADH
  source: MESH
  identifier: D009243
diseases: []
---
